Veracyte Announces Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. TFC
3. NEST:IN
4. AA
5. TECHM:IN
6. JBHT
7. MSCI
8. SCHW
9. CRWV
10. POLYCAB:IN

Go back to Veracyte Announces Second Quarter 2018 Financial Results

Veracyte (VCYT) Tops Q2 EPS by 9c, Revenues Beat; Boosts FY18 Revenue Guidance

July 23, 2018 4:11 PM EDT

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.18), $0.09 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $22.8 million versus the consensus estimate of $20.56 million.

We delivered another exceptional quarter of revenue and genomic test volume growth, said Bonnie Anderson, chairman and chief executive officer of Veracyte. We saw strong growth in our Afirma business where our deep... More